Intravenous Pamidronate Treatment in Children with Moderate-to-Severe Osteogenesis Imperfecta Started under Three Years of Age

Publisher： Karger

E-ISSN： 1663-2826|79|6|333-340

ISSN： 1663-2818

Source： Hormone Research in Paediatrics, Vol.79, Iss.6, 2013-05, pp. : 333-340

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pamidronate Treatment of Children with Moderate-to-Severe Osteogenesis Imperfecta: A Note of Caution

By  

Hormone Research in Paediatrics, Vol. 71, Iss. 1, 2008-11 ,pp. : 38-44

Karger

Access to resources Recommend Favorite

Decrease of Serum Alkaline Phosphatase after Three Cycles of Pamidronate Disodium in Children with Severe Osteogenesis Imperfecta

By  

Hormone Research in Paediatrics, Vol. 68, Iss. 5, 2007-12 ,pp. : 207-208

Karger

Access to resources Recommend Favorite

Intravenous Pamidronate Treatment Improves Growth in Prepubertal Osteogenesis Imperfecta Patients

By  

Hormone Research in Paediatrics, Vol. 75, Iss. 5, 2011-02 ,pp. : 354-361

Karger

Access to resources Recommend Favorite

Reshaping of Vertebrae during Treatment with Neridronate or Pamidronate in Children with Osteogenesis Imperfecta

By  

Hormone Research in Paediatrics, Vol. 76, Iss. 5, 2011-09 ,pp. : 321-327

Karger

Access to resources Recommend Favorite

The Long-Term Effects of Switching from Active Intravenous Bisphosphonate Treatment to Low-Dose Maintenance Therapy in Children with Osteogenesis Imperfecta

By  

Hormone Research in Paediatrics, Vol. 83, Iss. 3, 2015-02 ,pp. : 183-189

Karger

Access to resources Recommend Favorite